We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$20.3B
AUM Growth
+$1.22B
Cap. Flow
-$160M
Cap. Flow %
-0.79%
Top 10 Hldgs %
22.03%
Holding
1,796
New
121
Increased
266
Reduced
599
Closed
60

Top Buys

Rank Stock Value
1
TE
T1 Energy
TE
+$60.5M
2
PFE icon
Pfizer
PFE
+$44M
3
GXO icon
GXO Logistics
GXO
+$37.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$31.2M
5
JD icon
JD.com
JD
+$29.6M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$57.2M
2
BABA icon
Alibaba
BABA
+$57.2M
3
AMRC icon
Ameresco
AMRC
+$55.4M
4
SIVB
SVB Financial Group
SIVB
+$43.1M
5
WOLF icon
Wolfspeed
WOLF
+$41.1M

Sector Composition

Rank Sector Weight
1 Technology 25.22%
2 Healthcare 17.92%
3 Consumer Discretionary 13.84%
4 Financials 12.09%
5 Industrials 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIZZ icon
1626
National Beverage
FIZZ
$2.9B
$284K ﹤0.01%
6,258
+1,300
+26% +$70.7K
AXSM icon
1627
Axsome Therapeutics
AXSM
$11.2B
$283K ﹤0.01%
7,500
+1,300
+21% +$47.8K
PHR icon
1628
Phreesia
PHR
$758M
$283K ﹤0.01%
+6,800
New +$404K
CNDT icon
1629
Conduent
CNDT
$241M
$280K ﹤0.01%
52,399
MCY icon
1630
Mercury Insurance
MCY
$5.84B
$279K ﹤0.01%
5,258
AIV
1631
Aimco
AIV
$379M
$276K ﹤0.01%
35,748
CALM icon
1632
Cal-Maine
CALM
$3.86B
$275K ﹤0.01%
7,437
-3,000
-29% -$109K
AMRS
1633
DELISTED
Amyris Inc.
AMRS
$275K ﹤0.01%
50,800
-5,400
-10% -$50.4K
PRLB icon
1634
Protolabs
PRLB
$2.17B
$272K ﹤0.01%
5,300
SPNT icon
1635
SiriusPoint
SPNT
$2.66B
$272K ﹤0.01%
33,488
BLNK icon
1636
Blink Charging
BLNK
$85.6M
$270K ﹤0.01%
+10,200
New +$328K
CDE icon
1637
Coeur Mining
CDE
$19.3B
$270K ﹤0.01%
53,529
+2,500
+5% +$15K
ISEE
1638
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$268K ﹤0.01%
+16,000
New +$262K
LILAK icon
1639
Liberty Latin America Class C
LILAK
$1.67B
$267K ﹤0.01%
25,758
CCF
1640
DELISTED
Chase Corporation
CCF
$267K ﹤0.01%
2,686
BFLY icon
1641
Butterfly Network
BFLY
$2.52B
$265K ﹤0.01%
+39,600
New +$348K
CCCC icon
1642
C4 Therapeutics
CCCC
$480M
$264K ﹤0.01%
8,200
SGMO
1643
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$264K ﹤0.01%
35,246
TTCF
1644
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$264K ﹤0.01%
+17,000
New +$291K
MGNX icon
1645
MacroGenics
MGNX
$256M
$263K ﹤0.01%
16,400
+3,800
+30% +$71.5K
PRCH icon
1646
Porch Group
PRCH
$1.83B
$263K ﹤0.01%
+16,900
New +$325K
RVNC
1647
DELISTED
Revance Therapeutics, Inc.
RVNC
$263K ﹤0.01%
16,100
GPRO icon
1648
GoPro
GPRO
$106M
$262K ﹤0.01%
+25,400
New +$252K
NP
1649
DELISTED
Neenah, Inc. Common Stock
NP
$262K ﹤0.01%
5,665
KRA
1650
DELISTED
Kraton Corporation
KRA
$259K ﹤0.01%
+5,600
New +$257K

Similar funds

Handelsbanken Fonder's Q4 2021 Portfolio in Review

As of Q4 2021, Handelsbanken Fonder held 1,796 positions worth $20.3B, up 6.4% from $19.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Handelsbanken Fonder's Q4 2021 filing shows 121 new, 266 increased, 599 reduced and 60 closed positions. Its largest new stake was T1 Energy: 5,589,851 shares worth $62.5M. The largest sale was NVIDIA, an estimated $57.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q4 2021 buy was T1 Energy: 5,589,851 shares worth $62.5M.
  • Handelsbanken Fonder added most to Pfizer in Q4 2021, an estimated $44M increase.
  • Handelsbanken Fonder's biggest Q4 2021 reduction was NVIDIA, cutting an estimated $57.2M.
  • Handelsbanken Fonder fully exited Acceleron Pharma in Q4 2021, selling an estimated $27.5M.
  • Handelsbanken Fonder's ten largest holdings make up 22% of its $20.3B portfolio in Q4 2021.
  • Handelsbanken Fonder opened 121 new positions and closed 60 in Q4 2021.
  • Handelsbanken Fonder's portfolio value rose 6.4% quarter-over-quarter to $20.3B.

Based on Handelsbanken Fonder's 13F filing for Q4 2021, filed 8 Feb 2022.